Breast Cancer - Moose and Doc

A breast cancer explanations website

 

By Dr. Halls

References

 

The following is a list of research and references used for BIRADS Category Scale 2, 3, 4 and 5 Classifications.

 

  • Burnside ES, Ochsner JE, Fowler KJ, Fine JP, Salkowski LR, Rubin DL, Sisney GA. (2007) Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology. (2007 Feb) ;242(2):388-95. https://www.ncbi.nlm.nih.gov/pubmed/17255409
  • Eberl MM, Fox CH, Edge SB, Carter CA, Mahoney MC. (2006) BI-RADS classification for management of abnormal mammograms.J Am Board Fam Med.( 2006) Mar-Apr;19(2):161-4. http://www.jabfm.org/content/19/2/161.full
  • Hauth E, Umultlu L, Kummel S, Kimmig R. Forsting M. (2010) Follow-up of Probably Benign Lesions (BI-RADS 3 category) in Breast MR Imaging. The Breast Journal ( May/June 2010) Volume 16, Issue 3, pages 297–304
    https://www.ncbi.nlm.nih.gov/pubmed/20565469
  • Lacquement MA, Mitchell D, Hollingsworth AB (1999). Positive predictive value of the breast imaging reporting and data system. J Am Coll Surg 189: 34-40. https://www.ncbi.nlm.nih.gov/pubmed/10401738
  • Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD.(1998) The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol (1998); 171: 35–40 https://www.ncbi.nlm.nih.gov/pubmed/9648759
  • Monticciolo DL, Caplan LS. (2004) The American College of Radiology’s BI-RADS 3 classification in a nationwide screening program: current assessment and comparison with earlier use. Breast J (2004); 10: 106–10. https://www.ncbi.nlm.nih.gov/pubmed/15009036
  • Poplack SP, Tosteson AN, Grove MR, Wells WA, Carney PA. (2000) Mammography in 53,803 women from the New Hampshire mammography network. Radiology (2000); 217: 832–40. https://www.ncbi.nlm.nih.gov/pubmed/11110951
  • Raza S, Goldkamp AL, Chikarmane SA, Birdwell RL. (2010) US of breast masses categorized as BI-RADS 3, 4, and 5: pictorial review of factors influencing clinical management.Radiographics .( 2010 Sep);30(5):1199-213.
    https://www.ncbi.nlm.nih.gov/pubmed/20833845
  • Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehmen, CD. (2007) BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. The Breast Journal ( 2007) Volume 13, p. 545-550. https://www.ncbi.nlm.nih.gov/pubmed/17983393
  • Sanders, MA, Lane R, Sunati S. (2010) Clinical Implications of Subcategorizing BI-RADS 4 Breast Lesions associated with Microcalcification: A Radiology-Pathology Correlation Study. The Breast Journal (January/February 2010) Volume 16, Number 1, , pp. 28-31. https://www.ncbi.nlm.nih.gov/pubmed/19929890
  • Siegmann KC, Wersebe A, Fischmann A, Fersis N, Vogel U, Claussen CD, Muller-Schimpfle M (2003). Stereotactic vacuum-assisted breast biopsy-success, histologic accuracy, patient acceptance and optimizing the BI-RADS-correlated indication. Fortschr Rontgenstr 175: 99-104.
  • Varas X, Leborgne JH, Leborgne F, Mezzera J, Jaumandreu S, Leborgne F. (2002) Revisiting the mammographic follow-up of BI-RADS category 3 lesions. AJR Am J Roentgenol. (2002 Sep) ;179(3):691-5. https://www.ncbi.nlm.nih.gov/pubmed/12185047

Back to BIRADS Category Scale 2, 3, 4 and 5 Classifications.